R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Partner Content Partner Content Invite from the Chairman Hugues Malonne at the Molecular Dia... Invite from the Chairman Hugues Malonne at Molecular Dx
Partner Content Partner Content This Week's Spotlight Features GSK and Advanced Cell Diagnos... RNA Therapeutics Feb 2018
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.